Skip Nav Destination
Issues
1 October 2010
-
Cover Image
Cover Image
The antibody-linked maytansinoid DM1 conjugate and its intracellular metabolites bind to microtubule ends and suppress microtubule dynamics with high potency at subnanomolar concentrations, thus arresting mitosis and inhibiting tumor cell proliferation. Using immunofluorescence microscopy, the MCF7 breast cancer cell is shown arrested in an abnormal mitosis after incubation with 340 pmol/L of the metabolite S-methyl DM1 (the concentration that half-maximally arrests mitosis) and exhibits uncongressed chromosomes (blue) located at one of the spindle poles which is marked by anti-pericentrin staining (red). Microtubules are green. For details, see articles by Oroudjev and colleagues on page 2700 and Lopus and colleagues on page 2689.Close Modal - PDF Icon PDF LinkTable of Contents
ISSN 1535-7163
EISSN 1538-8514
Highlights
Therapeutic Discovery
Context-Dependent Role of Angiopoietin-1 Inhibition in the Suppression of Angiogenesis and Tumor Growth: Implications for AMG 386, an Angiopoietin-1/2–Neutralizing Peptibody
Angela Coxon; James Bready; Hosung Min; Stephen Kaufman; Juan Leal; Dongyin Yu; Tani Ann Lee; Ji-Rong Sun; Juan Estrada; Brad Bolon; James McCabe; Ling Wang; Karen Rex; Sean Caenepeel; Paul Hughes; David Cordover; Haejin Kim; Seog Joon Han; Mark L. Michaels; Eric Hsu; Grant Shimamoto; Russell Cattley; Eunju Hurh; Linh Nguyen; Shao Xiong Wang; Anthony Ndifor; Isaac J. Hayward; Beverly L. Falcón; Donald M. McDonald; Luke Li; Tom Boone; Richard Kendall; Robert Radinsky; Jonathan D. Oliner
Compensatory Insulin Receptor (IR) Activation on Inhibition of Insulin-Like Growth Factor-1 Receptor (IGF-1R): Rationale for Cotargeting IGF-1R and IR in Cancer
Elizabeth Buck; Prafulla C. Gokhale; Susan Koujak; Eric Brown; Alexandra Eyzaguirre; Nianjun Tao; Maryland Rosenfeld-Franklin; Lorena Lerner; M. Isabel Chiu; Robert Wild; David Epstein; Jonathan A. Pachter; Mark R. Miglarese
The Use of One-Bead One-Compound Combinatorial Library Technology to Discover High-Affinity αvβ3 Integrin and Cancer Targeting Arginine-Glycine-Aspartic Acid Ligands with a Built-in Handle
Wenwu Xiao; Yan Wang; Edmond Y. Lau; Juntao Luo; Nianhuan Yao; Changying Shi; Leah Meza; Harry Tseng; Yoshiko Maeda; Pappanaicken Kumaresan; Ruiwu Liu; Felice C. Lightstone; Yoshikazu Takada; Kit S. Lam
Preclinical Development
Aflibercept Exerts Antivascular Effects and Enhances Levels of Anthracycline Chemotherapy In vivo in Human Acute Myeloid Leukemia Models
Deepika Lal; Jennifer A. Park; Kellie Demock; Joseph Marinaro; Amanda M. Perez; Mei-Hui Lin; Lili Tian; Terry J. Mashtare; Michael Murphy; Joshua Prey; Meir Wetzler; Gerald J. Fetterly; Eunice S. Wang
TAK-701, a Humanized Monoclonal Antibody to Hepatocyte Growth Factor, Reverses Gefitinib Resistance Induced by Tumor-Derived HGF in Non–Small Cell Lung Cancer with an EGFR Mutation
Wataru Okamoto; Isamu Okamoto; Kaoru Tanaka; Erina Hatashita; Yuki Yamada; Kiyoko Kuwata; Haruka Yamaguchi; Tokuzo Arao; Kazuto Nishio; Masahiro Fukuoka; Pasi A. Jänne; Kazuhiko Nakagawa
Molecular Medicine in Practice
Phase I Safety, Pharmacokinetic, and Biomarker Study of BIBF 1120, an Oral Triple Tyrosine Kinase Inhibitor in Patients with Advanced Solid Tumors
Isamu Okamoto; Hiroyasu Kaneda; Taroh Satoh; Wataru Okamoto; Masaki Miyazaki; Ryotaro Morinaga; Shinya Ueda; Masaaki Terashima; Asuka Tsuya; Akiko Sarashina; Koichi Konishi; Tokuzo Arao; Kazuto Nishio; Rolf Kaiser; Kazuhiko Nakagawa
Phase I Study of the Selective Aurora A Kinase Inhibitor MLN8054 in Patients with Advanced Solid Tumors: Safety, Pharmacokinetics, and Pharmacodynamics
Teresa Macarulla; Andres Cervantes; Elena Elez; Edith Rodríguez-Braun; José Baselga; Susana Roselló; Gemma Sala; Inma Blasco; Hadi Danaee; Yih Lee; Jeffrey Ecsedy; Vaishali Shinde; Arijit Chakravarty; Douglas Bowman; Hua Liu; Omar Eton; Howard Fingert; Josep Tabernero
Letters to the Editor
Corrections
Advertisement